6 Common Misconceptions About Peptic Ulcer Disease

Why Peptic Ulcer Myths Still Persist

For years, ulcers were commonly blamed on a stressful job, a fondness for spicy meals, or other everyday habits. Those explanations remain familiar, even though research now points elsewhere. The two most common causes are infection with Helicobacter pylori (H. pylori) and use of nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, ibuprofen, and naproxen.

A peptic ulcer is a sore in the lining of the stomach or the duodenum, the first part of the small intestine. It is not simply another name for indigestion, heartburn, or any episode of upper-abdominal discomfort. Symptoms can overlap with other digestive problems, so a symptom pattern by itself cannot establish the diagnosis. The Peptic Ulcer Disease overview provides additional background on causes, symptoms, and complications.

Misconceptions matter because they can influence what a person does next. Someone who assumes stress is the entire explanation may focus only on relaxation. Another person may dismiss regular over-the-counter NSAID use as harmless. Reliable information helps patients discuss appropriate testing, medication review, and follow-up with a clinician rather than trying to identify or treat an ulcer on their own.

Treatment depends on the cause. If testing identifies H. pylori, symptom relief alone is not enough. The infection requires combination eradication therapy selected by a clinician. Prior antibiotic exposure, susceptibility information, allergies, medical history, and other individual considerations can affect that choice, so a regimen that is appropriate for one patient may not be appropriate for another.

For treatment-naive adults, the 2024 ACG guideline identifies optimized bismuth quadruple therapy for 14 days as a recommended empiric option. It includes a PPI, tetracycline, metronidazole, and bismuth. The guideline recommends against empiric PPI-clarithromycin triple therapy unless clarithromycin susceptibility has been demonstrated because resistance reduces efficacy. This guidance should inform a clinician’s decision rather than be used as a self-treatment plan.

An NSAID-associated ulcer calls for a different discussion. Clinician-directed options may include stopping the NSAID, changing it, reducing the dose, using another pain medicine, or considering a PPI if NSAID therapy must continue. The decision depends partly on why the medicine is being used and on the person’s gastrointestinal and cardiovascular risks. Do not independently stop prescribed aspirin or another NSAID. Review it with the prescribing clinician instead. Read more about peptic ulcer treatment options and the role of cause-directed care.

The distinction between symptoms and diagnosis is important. Upper-abdominal discomfort can have more than one explanation, while a clinically important ulcer may cause little or no discomfort. A clinician can review the symptom pattern, medication history, previous H. pylori results, and other relevant information before deciding which tests are appropriate.

Warning signs require a different response from routine digestive discomfort. Black or tarry stool, maroon or red blood in stool, vomiting blood or coffee-ground material, sudden severe abdominal pain, dizziness, fainting, rapid pulse, or signs of shock require immediate medical attention. These findings may indicate bleeding, perforation, or another serious problem and should not be managed with home remedies.

A clinician may suspect peptic ulcer disease after reviewing symptoms and risk factors, but symptoms alone cannot reliably confirm it. The evaluation may address two related questions: whether an ulcer is present and whether H. pylori is involved. The tests used for those questions do not all provide the same information.

A urea breath test or stool antigen test can detect active H. pylori infection. These noninvasive tests do not directly show the stomach or duodenum, however, and they cannot visualize an ulcer or active bleeding. Upper-GI endoscopy can examine the esophagus, stomach, and duodenum directly, confirm an ulcer, and allow biopsies when indicated. It can also help investigate an ulcer’s cause or complications. See how peptic ulcers are diagnosed for an overview of the evaluation process.

Endoscopy is also an important diagnostic and therapeutic tool in bleeding peptic ulcer disease. In hospitalized patients, early endoscopy can support diagnosis, risk assessment, and treatment to stop bleeding. Ulcers with active bleeding, a visible vessel, or an adherent clot may require endoscopic therapy. This does not mean that everyone with indigestion needs urgent endoscopy; the decision depends on the clinical situation.

Testing continues after H. pylori treatment. The ACG guideline recommends confirming eradication with a fecal antigen test, urea breath test, or gastric biopsy at least four weeks after antibiotic therapy. PPIs or potassium-competitive acid blockers should be withheld for at least two weeks before that testing under the treating clinician’s direction because medication timing can affect accuracy.

Good information does not replace an evaluation, but it can make the conversation more productive. Before an appointment, gather a complete medication list, including over-the-counter products, and note any previous ulcer or H. pylori test results. Be specific about symptoms and about any signs of bleeding rather than assuming every episode of discomfort has the same cause.

• Ask whether H. pylori testing is relevant. If an ulcer is suspected or confirmed, ask whether you have been tested and what the result means for treatment.
• Include every NSAID in your medication review. Mention aspirin, ibuprofen, and naproxen, including products purchased without a prescription. Frequency, dose, duration, and use of more than one NSAID are relevant.
• Do not change prescribed medicines independently. Aspirin or another NSAID may have been recommended for an important reason. A clinician can weigh that reason against gastrointestinal risk and discuss available options.
• Follow the prescribed H. pylori regimen. Combination therapy is intended to eradicate the infection, not merely to change symptoms. Contact the treating clinician if you have questions about how to take it.
• Complete follow-up testing. Improvement does not verify eradication. Follow the clinician’s instructions about test timing and temporary medication holds.
• Respond promptly to warning signs. Vomiting blood, coffee-ground vomit, black or bloody stool, sudden severe abdominal pain, dizziness, fainting, rapid pulse, or signs of shock require immediate medical attention.

• Upper-abdominal pain, burning, or discomfort that persists or repeatedly returns.
• Nausea, vomiting, early fullness, uncomfortable fullness after meals, bloating, or belching that warrants medical evaluation.
• Digestive symptoms occurring in the setting of regular aspirin, ibuprofen, naproxen, or other NSAID use.
• A previous positive H. pylori result without documented post-treatment testing to confirm eradication.
• A suspected or confirmed ulcer that requires a discussion of testing, treatment, or medication use.
• Questions about whether upper-GI endoscopy is appropriate for confirming an ulcer, obtaining a biopsy, or assessing a possible complication.
• Black or tarry stool, red or maroon blood in stool, vomiting blood or coffee-ground material, sudden severe abdominal pain, dizziness, fainting, rapid pulse, or signs of shock. Seek immediate medical attention for these warning signs rather than waiting for a routine visit.